CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer
MaxCyte’s Flow Electroporation technology and ExPERT platform to support the development of Adicet’s gamma delta T cell therapy gene edited programs
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
As cell line development (CLD) programs grow in complexity and scale, with increasing demands for speed, data quality, and adaptability, it is essential to choose the right analytical tools that will future-proof your workflow.
Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific
With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship
